SCIEX and CW Analytical collaborate to develop first cannabis testing standards

Published: 14-Sep-2016
Analysis

SCIEX workflow solution enables legalised cannabis labs to facilitate routine testing with robust, cost-effective analytical methods


SCIEX, a leader in life science analytical technologies, has entered into a collaboration with marijuana testing laboratory CW Analytical to develop fully validated, standardised methods to measure pesticides and cannabinoids in cannabis and cannabis-related products.

This collaboration will provide the cannabis industry with comprehensive, cost-effective analytical methods to facilitate routine testing with guidance and expected performance.

As global demand for cannabis quality testing solutions rises, analytical labs must look to mass spectrometry-based (MS) solutions for the accuracy and reliability to ensure product safety and regulatory compliance. SCIEX will provide CWAL with LC-MS/MS expertise and instrumentation including the SCIEX Triple Quad 3500 System, with MultiQuant Software for processing multiple analytes and samples. Additionally, SCIEX will provide CWAL with onsite technical expertise to obtain optimal detection, recovery and run-time for quantifying pesticides, aflatoxins and cannabinoids.

'The global cannabis testing industry does not currently have a standard method for the analysis of pesticides and cannabinoids, and together with CW Analytical, we look forward to implementing a method which can be used by all labs doing such an analysis,' said Vincent Paez, Senior Director of Food, Environmental and Forensics Testing at SCIEX.

'This project will enable CW Analytical to ensure chemical pesticides, the presence of aflatoxins and potency levels are accurately measured and reported for medical marijuana samples in a timely, affordable manner,' said Dr Robert Martin, Co­Founde and Chief Operating Officer at CW Analytical. 'LC-MS/MS is a key technology for us to apply to our day to day testing needs. The ability to analyse accurately hundreds of samples a day offers a unique level of efficiency to our laboratory.'

  • Companies:
  • AB Sciex
  • CW Analytical
See more

You may also like

Analysis

QTOF mass spectrometry for faster biotherapeutics characterisation

Read more
Sciex focuses on reproducible data and education for biologics labs with the X500B QTOF at World ADC Summit

Trending Articles

  1. Isospec Analytics launches biomolecular analysis technology to identify unknown molecules The novel technology optimises the identification process of unknown molecules compared to mass analysis
  2. IMPACT CKD model reveals the escalating toll of chronic kidney disease The model projects up to 125 million of the population across eight countries to suffer from chronic kidney disease by 2032
  3. Edward Rayner appointed as as Non-Executive Director of Sphere Fluidics Ed’s appointment will strengthen the company’s strategic vision as it progresses ambitious plans for future growth and commercial success
  4. Beckman introduces novel CE-Marked Hepatitis Assays at ESCMID Global The HBsAg high positive algorithm eliminates the need for repeat and confirmatory testing for samples ≥ 100.00 S/CO
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Meeting new USP Chapter 41 requirements Balances are the essential means by which all therapeutics are ultimately supplied in safe dosages. Dirk Ahlbrecht, Sartorius Group, looks at how to ensure measurements are both accurate and up to new USP standards

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Analysis

QTOF mass spectrometry for faster biotherapeutics characterisation

Sciex focuses on reproducible data and education for biologics labs with the X500B QTOF at World ADC Summit
Research & Development

Scientists eradicate leukemic stem cells by targeting cell survival proteins

SCIEX mass spectrometry-based solutions lead to leukemia breakthroughs – advancing precision medicine
Research & Development

SCIEX joins forces with the Francis Crick Institute and the University of Cambridge to establish understanding of metabolism

New proteomic study to develop advanced resource for precision medicine research by using Microflow SWATH acquisition
Analysis

University of Manchester and SCIEX open £18m Biomarker Discovery Centre

The Manchester, UK-based Stoller Biomarker Discovery Centre is a major step forward in precision medicine and making 'industrial' proteomics a reality
Finance

AB Sciex to combine Eksigent chromatography with capillary electrophoresis from Beckman Coulter

With the aim of advancing separations science and extending technology leadership, synergies and market presence
Analysis

AB Sciex acquires mass spectrometry business of Labindia Instruments

Broadens presence in India
Research & Development

AB Sciex to accelerate use of dried blood spot analysis

Offers cost savings and higher productivity
Subscribe now